396 related articles for article (PubMed ID: 20015867)
1. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
Balasubramanian S; Adhikary G; Eckert RL
Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
[TBL] [Abstract][Full Text] [Related]
2. (-)-Epigallocatechin-3-gallate and DZNep reduce polycomb protein level via a proteasome-dependent mechanism in skin cancer cells.
Choudhury SR; Balasubramanian S; Chew YC; Han B; Marquez VE; Eckert RL
Carcinogenesis; 2011 Oct; 32(10):1525-32. PubMed ID: 21798853
[TBL] [Abstract][Full Text] [Related]
3. The Bmi-1 helix-turn and ring finger domains are required for Bmi-1 antagonism of (-) epigallocatechin-3-gallate suppression of skin cancer cell survival.
Balasubramanian S; Scharadin TM; Han B; Xu W; Eckert RL
Cell Signal; 2015 Jul; 27(7):1336-44. PubMed ID: 25843776
[TBL] [Abstract][Full Text] [Related]
4. Expression of Bmi-1 in epidermis enhances cell survival by altering cell cycle regulatory protein expression and inhibiting apoptosis.
Lee K; Adhikary G; Balasubramanian S; Gopalakrishnan R; McCormick T; Dimri GP; Eckert RL; Rorke EA
J Invest Dermatol; 2008 Jan; 128(1):9-17. PubMed ID: 17625597
[TBL] [Abstract][Full Text] [Related]
5. Essential role for activation of the Polycomb group (PcG) protein chromatin silencing pathway in metastatic prostate cancer.
Berezovska OP; Glinskii AB; Yang Z; Li XM; Hoffman RM; Glinsky GV
Cell Cycle; 2006 Aug; 5(16):1886-901. PubMed ID: 16963837
[TBL] [Abstract][Full Text] [Related]
6. The Bmi-1 polycomb group gene in skin cancer: regulation of function by (-)-epigallocatechin-3-gallate.
Balasubramanian S; Lee K; Adhikary G; Gopalakrishnan R; Rorke EA; Eckert RL
Nutr Rev; 2008 Aug; 66 Suppl 1(Suppl 1):S65-8. PubMed ID: 18673494
[No Abstract] [Full Text] [Related]
7. Differential responses of skin cancer-chemopreventive agents silibinin, quercetin, and epigallocatechin 3-gallate on mitogenic signaling and cell cycle regulators in human epidermoid carcinoma A431 cells.
Bhatia N; Agarwal C; Agarwal R
Nutr Cancer; 2001; 39(2):292-9. PubMed ID: 11759294
[TBL] [Abstract][Full Text] [Related]
8. Inner workings and regulatory inputs that control Polycomb repressive complex 2.
O'Meara MM; Simon JA
Chromosoma; 2012 Jun; 121(3):221-34. PubMed ID: 22349693
[TBL] [Abstract][Full Text] [Related]
9. Sulforaphane suppresses polycomb group protein level via a proteasome-dependent mechanism in skin cancer cells.
Balasubramanian S; Chew YC; Eckert RL
Mol Pharmacol; 2011 Nov; 80(5):870-8. PubMed ID: 21807989
[TBL] [Abstract][Full Text] [Related]
10. Role of p53 and NF-kappaB in epigallocatechin-3-gallate-induced apoptosis of LNCaP cells.
Hastak K; Gupta S; Ahmad N; Agarwal MK; Agarwal ML; Mukhtar H
Oncogene; 2003 Jul; 22(31):4851-9. PubMed ID: 12894226
[TBL] [Abstract][Full Text] [Related]
11. Polycomb-group oncogenes EZH2, BMI1, and RING1 are overexpressed in prostate cancer with adverse pathologic and clinical features.
van Leenders GJ; Dukers D; Hessels D; van den Kieboom SW; Hulsbergen CA; Witjes JA; Otte AP; Meijer CJ; Raaphorst FM
Eur Urol; 2007 Aug; 52(2):455-63. PubMed ID: 17134822
[TBL] [Abstract][Full Text] [Related]
12. A Noncanonical Function of Polycomb Repressive Complexes Promotes Human Cytomegalovirus Lytic DNA Replication and Serves as a Novel Cellular Target for Antiviral Intervention.
Svrlanska A; Reichel A; Schilling EM; Scherer M; Stamminger T; Reuter N
J Virol; 2019 May; 93(9):. PubMed ID: 30814291
[TBL] [Abstract][Full Text] [Related]
13. The knock-down of overexpressed EZH2 and BMI-1 does not prevent osteosarcoma growth.
Sasaki H; Setoguchi T; Matsunoshita Y; Gao H; Hirotsu M; Komiya S
Oncol Rep; 2010 Mar; 23(3):677-84. PubMed ID: 20127006
[TBL] [Abstract][Full Text] [Related]
14. Increased expression of the EZH2 polycomb group gene in BMI-1-positive neoplastic cells during bronchial carcinogenesis.
Breuer RH; Snijders PJ; Smit EF; Sutedja TG; Sewalt RG; Otte AP; van Kemenade FJ; Postmus PE; Meijer CJ; Raaphorst FM
Neoplasia; 2004; 6(6):736-43. PubMed ID: 15720799
[TBL] [Abstract][Full Text] [Related]
15. Poorly differentiated breast carcinoma is associated with increased expression of the human polycomb group EZH2 gene.
Raaphorst FM; Meijer CJ; Fieret E; Blokzijl T; Mommers E; Buerger H; Packeisen J; Sewalt RA; Otte AP; van Diest PJ
Neoplasia; 2003; 5(6):481-8. PubMed ID: 14965441
[TBL] [Abstract][Full Text] [Related]
16. FOXC1, a target of polycomb, inhibits metastasis of breast cancer cells.
Du J; Li L; Ou Z; Kong C; Zhang Y; Dong Z; Zhu S; Jiang H; Shao Z; Huang B; Lu J
Breast Cancer Res Treat; 2012 Jan; 131(1):65-73. PubMed ID: 21465172
[TBL] [Abstract][Full Text] [Related]
17. Implication of polycomb members Bmi-1, Mel-18, and Hpc-2 in the regulation of p16INK4a, p14ARF, h-TERT, and c-Myc expression in primary breast carcinomas.
Silva J; García JM; Peña C; García V; Domínguez G; Suárez D; Camacho FI; Espinosa R; Provencio M; España P; Bonilla F
Clin Cancer Res; 2006 Dec; 12(23):6929-36. PubMed ID: 17145810
[TBL] [Abstract][Full Text] [Related]
18. Polycomb group protein-associated chromatin is reproduced in post-mitotic G1 phase and is required for S phase progression.
Aoto T; Saitoh N; Sakamoto Y; Watanabe S; Nakao M
J Biol Chem; 2008 Jul; 283(27):18905-15. PubMed ID: 18453536
[TBL] [Abstract][Full Text] [Related]
19. Enhancer of zeste homolog 2 promotes the proliferation and invasion of epithelial ovarian cancer cells.
Li H; Cai Q; Godwin AK; Zhang R
Mol Cancer Res; 2010 Dec; 8(12):1610-8. PubMed ID: 21115743
[TBL] [Abstract][Full Text] [Related]
20. Association of BMI1 with polycomb bodies is dynamic and requires PRC2/EZH2 and the maintenance DNA methyltransferase DNMT1.
Hernández-Muñoz I; Taghavi P; Kuijl C; Neefjes J; van Lohuizen M
Mol Cell Biol; 2005 Dec; 25(24):11047-58. PubMed ID: 16314526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
